Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(12/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(12/week)
News
United States
(499/week)
Manufacturing
(342/week)
Energy
(283/week)
Technology
(381/week)
Alternative Energy
(143/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Everest Medicines
Mar 19, 2024
Everest Medicines Announces Singapore Health Sciences Authority Approves NEFEGAN® for the Treatment of Primary IgA Nephropathy in Adult Patients
Mar 11, 2024
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
Mar 10, 2024
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau
Mar 05, 2024
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
Feb 26, 2024
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Feb 21, 2024
Everest Medicines' Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
Feb 20, 2024
Everest Medicines' Licensing Partner Venatorx Pharmaceuticals Announces Publication of Positive Results from Cefepime-Taniborbactam's Phase 3 CERTAIN-1 Study in New England Journal of Medicine
Feb 18, 2024
Everest Medicines Announces Termination of Collaboration Agreements with Providence
Jan 21, 2024
Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million
Feb 17, 2021
Everest Medicines Appoints Kevin Guo as Chief Commercial Officer
Jan 18, 2021
Everest Medicines Announces Amended Agreement with Spero Therapeutics
Jan 06, 2021
Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer
Jan 06, 2021
Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer
Latest News
May 17, 2024
EnerSys Secures Energy Storage Product of the Year Award
May 17, 2024
Cyber Flex Launches: Transforming Vaping with Superior Technology and Style
May 17, 2024
Best Solution Windows and Doors Leads DEL Manufacturing's Expansion into Alberta
May 17, 2024
Pleasant Valley Solar Project Partners Commit $123,000 in Scholarship Funds to Boise State University and...
May 17, 2024
Halliburton Annual Meeting of Shareholders and Dividend Declaration
May 17, 2024
La Corée du Nord lance au moins un "missile balistique non identifié"
May 17, 2024
Crisis-ridden Boeing prepares for turbulence at annual meeting
May 17, 2024
Crisis-ridden Boeing hopes for quiet annual meeting
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events